Richard S. Geary, EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC (IONS), sold 2,430 shares at $48.00 ($117K) on 2024-08-05, disclosed to the SEC on 2024-08-06.
Scheduled sale ($117k) by EVP, Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| IONS | SELL | 2025-11-03 | $11.9M | — | Filing → |
| IONS | SELL | 2025-10-01 | $7.6M | — | Filing → |
| IONS | SELL | 2025-09-04 | $504K | — | Filing → |